Switch theme
Sign up to access all valuation multiples
Hengan International is a leading personal care product manufacturer in China. Its business comprises tissue paper products (close to 60% of sales), sanitary napkins (26% of sales), disposable diapers (5% of sales), and others.
1998
23K+
LTM Revenue $3.3B
LTM EBITDA $564M
$3.0B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Hengan Group has a last 12-month revenue of $3.3B and a last 12-month EBITDA of $564M.
In the most recent fiscal year, Hengan Group achieved revenue of $2.9B and an EBITDA of $570M.
Hengan Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Hengan Group valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $3.1B | $2.9B | XXX | XXX | XXX |
| Gross Profit | $989M | $1.0B | XXX | XXX | XXX |
| Gross Margin | 32% | 35% | XXX | XXX | XXX |
| EBITDA | $661M | $570M | XXX | XXX | XXX |
| EBITDA Margin | 22% | 20% | XXX | XXX | XXX |
| Net Profit | $248M | $360M | XXX | XXX | XXX |
| Net Margin | 8% | 12% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Hengan Group's stock price is HKD 21 (or $3).
Hengan Group has current market cap of HKD 24.2B (or $3.1B), and EV of HKD 22.9B (or $3.0B).
See Hengan Group trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3.0B | $3.1B | XXX | XXX | XXX | XXX | $0.28 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Hengan Group has market cap of $3.1B and EV of $3.0B.
Hengan Group's trades at 0.9x LTM EV/Revenue multiple, and 5.6x LTM EBITDA.
Analysts estimate Hengan Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Hengan Group and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $3.0B | XXX | XXX | XXX |
| EV/Revenue | 1.0x | XXX | XXX | XXX |
| EV/EBITDA | 5.2x | XXX | XXX | XXX |
| P/E | 10.5x | XXX | XXX | XXX |
| P/E/Growth | 1.8x | XXX | XXX | XXX |
| EV/FCF | 15.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpHengan Group's NTM/LTM revenue growth is 0%
Hengan Group's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $26K for the same period.
Over next 12 months, Hengan Group's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Hengan Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Hengan Group and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | -5% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 20% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -14% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 20% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
| Opex per Employee | $26K | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 16% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 6% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 20% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
| EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
| Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Hengan Group acquired XXX companies to date.
Last acquisition by Hengan Group was XXXXXXXX, XXXXX XXXXX XXXXXX . Hengan Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Hengan Group founded? | Hengan Group was founded in 1998. |
| Where is Hengan Group headquartered? | Hengan Group is headquartered in Hong Kong. |
| How many employees does Hengan Group have? | As of today, Hengan Group has 23K+ employees. |
| Who is the CEO of Hengan Group? | Hengan Group's CEO is Mr. Ching Lau Hui. |
| Is Hengan Group publicy listed? | Yes, Hengan Group is a public company listed on HKG. |
| What is the stock symbol of Hengan Group? | Hengan Group trades under 01044 ticker. |
| When did Hengan Group go public? | Hengan Group went public in 1998. |
| Who are competitors of Hengan Group? | Similar companies to Hengan Group include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm. |
| What is the current market cap of Hengan Group? | Hengan Group's current market cap is $3.1B |
| What is the current revenue of Hengan Group? | Hengan Group's last 12-month revenue is $3.3B. |
| What is the current EBITDA of Hengan Group? | Hengan Group's last 12-month EBITDA is $564M. |
| What is the current EV/Revenue multiple of Hengan Group? | Current revenue multiple of Hengan Group is 0.9x. |
| What is the current EV/EBITDA multiple of Hengan Group? | Current EBITDA multiple of Hengan Group is 5.6x. |
| What is the current revenue growth of Hengan Group? | Hengan Group revenue growth between 2023 and 2024 was -5%. |
| Is Hengan Group profitable? | Yes, Hengan Group is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
